TessArae Blog
News and Events from TessArae, LLC
TessArae, LLC and Chinese esoteric laboratory, Kindstar Global, secure partnership for development of genetic tests.
POTOMAC FALLS, Va., April 25, 2013 /PRNewswire/ – TessArae®, LLC and Kindstar Global, the largest esoteric reference laboratory in China, have signed a collaboration agreement for the development of a pan-ethnic carrier screen for the Chinese population. The assay, which will be run in Kindstar’s laboratories in China, employs TessArae’s targeted sequencing development platform and proprietary bioanalysis software. The agreement [...]
Posted in Press Releases | No Comments
TessArae to Attend ASHG 2012 Annual Meeting
Come and learn about our targeted sequencing applications at the 2012 American Society of Human Genetics Meeting in San Francisco November 6-10. Contact us at info@tessarae.com for more information. http://www.ashg.org/2012meeting/
Posted in Uncategorized | No Comments
Dr. Matthew Lorence to chair session at the Point-of-Care Dx session on Novel POC Devices.
Dr. Matthew Lorence will chair a session in the Enabling Point-of-Care Diagnostics conference, which is part of the Next Generation Diagnostics Summit, held in Washington, DC on August 21-22. The session will include a speaker from the Clinton Health Access Initiative presenting on the feasibility of POC Diagnostics in developing countries. Details can be found [...]
Posted in Uncategorized | No Comments
Israeli Testing Firm GGA Rolls out Array-Based Cancer Gene Resequencing Service.
Kazerin-based GGA designed the chip with TessArae, a Potomac Falls, Va.-based company that develops targeted sequencing applications for human genetic disease and microbial identification. GGA and TessArae have been working on the array for several years. Read more in BioArray News (subscription required).
Posted in News, Uncategorized | No Comments
Come Visit TessArae at ESHG 2012 June 24-26
Come visit us at booth #615 June 24-26 and learn about our targeted sequencing assays and the power of our GeneCipher™ automated analysis. TessArae helps your lab develop targeted sequencing assays for human genetic diseases. Make us your partner. We help you get from assay concept to clinical validation, quickly and easily. https://www.eshg.org/336.0.html
Posted in Uncategorized | No Comments
TessArae to Exhibit at 2012 ACMG Annual Clinical Genetics Meeting
Come visit us at booth #211 March 28-30th and learn about our GeneCipher™ targeted sequencing assays. Click here for more details: http://bit.ly/GFP2bm TessArae GeneCipher™ targeted sequencing assays provide unmatched performance for genetic disease testing in a microarray-based format. Through proprietary assay design and analysis algorithms, TessArae gives you the power to perform comprehensive carrier screening [...]
Posted in Meetings, News | No Comments
TessArae CEO Dr. Klaus Schafer to Speak at Annual Wharton Alumni Healthcare Conference
Annual Wharton Alumni Healthcare Conference Please join us for this all-day event with great topics and numerous national healthcare leaders confirmed as speakers Saturday, October 22, 2011 8:15am – 6:00pm “At the intersection of policy, implementation, and innovation in the healthcare industry” Jon M. Huntsman Hall 3730 Walnut Street Philadelphia, PA 19104-3615 Click here [...]
Posted in Uncategorized | No Comments
TessArae, LLC Taps L. Thomas Richards, M.D. as President
POTOMAC FALLS, Va., June 8, 2011 /PRNewswire/ — TessArae®, LLC, a privately held company, today announced that it has appointed Tom Richards as its new President. Dr. Richards has held faculty positions at Stanford University Medical Center and UCSF Medical Center, where he currently practices as an Assistant Clinical Professor in the Department of Emergency [...]
Posted in News, Press Releases | No Comments
TessArae to Exhibit at 2011 Annual Clinical Genetics Meeting (ACMG)
Come and visit us at booth 120 at the 2011 ACMG meeting in Vancouver, BC Canada. Learn about our GeneCipher™ Assay for genetic disease testing. More information at the ACMG Conference Website.
Posted in News | No Comments
Dr. Matthew Lorence to Chair Session at Molecular Med Tri-Con 2011
Dr. Matthew Lorence, Vice President, Marketing and Sales for Tessarae, LLC will chair the Growth in Personalized Cancer Diagnostics session of the Cancer Molecular Markers program at Molecular Med Tri-Con 2011. The session will be Friday February 25, 2011 at the Moscone North Convention Center, San Francisco, CA at 8:30am. 18th International Molecular Medicine Tri-Conference – [...]
Posted in Meetings, News | No Comments